T Scientific Co., Ltd.

As of March 31, 2026, T Scientific Co., Ltd. carries a market capitalization of 43.39B, placing it among publicly traded companies globally. Its enterprise value stands at 37.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, T Scientific Co., Ltd. has 14.25M shares outstanding.

As of March 31, 2026, T Scientific Co., Ltd. trades at a trailing price-to-earnings ratio of 36.52. The price-to-sales ratio is 1.22, and the price-to-book ratio stands at 0.26.

As of March 31, 2026, T Scientific Co., Ltd. trades at an EV/EBITDA multiple of 37.34 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 354.48 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 37.96B versus a market cap of 43.39B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, T Scientific Co., Ltd. maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.00, indicating elevated leverage, while an interest coverage ratio of 1.13 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, T Scientific Co., Ltd. posted a return on equity (ROE) of 0.77, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.66, measuring how efficiently the asset base is converted into earnings. The company generates approximately 147.83M in revenue per employee across its workforce of 241.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 43.31 indicates how many times T Scientific Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, T Scientific Co., Ltd.'s stock has declined approximately 71.88% over the past 52 weeks. The 50-day moving average sits at 1,648.54, while the 200-day moving average is 2,588.60.

Over the twelve months ended March 31, 2026, T Scientific Co., Ltd. generated 35.70B in revenue and converted that into 1.19B in net income, yielding earnings per share of 63.21. EBITDA reached 1.02B, while operating income came in at 107.08M.

As of March 31, 2026, T Scientific Co., Ltd. holds 10.70B in cash and equivalents against 6.72B in total debt, resulting in a net debt position of -4.12B. Total book value stands at 169.31B, with working capital of 11.74B providing operational flexibility.

T Scientific Co., Ltd. produced 245.96M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -139.77M in capital expenditures, free cash flow totaled 106.19M - equivalent to 7.45 per share.

Over the twelve months ended March 31, 2026, T Scientific Co., Ltd. posted a gross margin of 29.96, reflecting its pricing power and cost economics. The operating margin of 0.30 and net profit margin of 3.33 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 0.24, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 11.09, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to T Scientific Co., Ltd. shareholders.

T Scientific Co., Ltd.'s most recent stock split took place on April 30, 2026 with a 5:1 split ratio.

As of March 31, 2026, T Scientific Co., Ltd. has an Altman Z-Score of 0.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.